Telomir Pharmaceuticals Inc [NASDAQ: TELO] closed the trading session at $1.21 on 2025-07-17. The day’s price range saw the stock hit a low of $1.1502, while the highest price level was $1.22.
The stocks have a year to date performance of -70.77 percent and weekly performance of 3.42 percent. The stock has been moved at -73.58 percent over the last six months. The stock has performed -39.50 percent around the most recent 30 days and changed -53.82 percent over the most recent 3-months.
If compared to the average trading volume of 262.07K shares, TELO reached to a volume of 8594274 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Telomir Pharmaceuticals Inc [TELO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TELO shares is $15.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TELO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Rodman & Renshaw have made an estimate for Telomir Pharmaceuticals Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 21, 2025.
TELO stock trade performance evaluation
Telomir Pharmaceuticals Inc [TELO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.42. With this latest performance, TELO shares dropped by -39.50% in over the last four-week period, additionally sinking by -73.58% over the last 6 months – not to mention a drop of -70.63% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TELO stock in for the last two-week period is set at 31.28, with the RSI for the last a single of trading hit 0.0915, and the three-weeks RSI is set at 0.1422 for Telomir Pharmaceuticals Inc [TELO]. The present Moving Average for the last 50 days of trading for this stock 1.8762, while it was recorded at 1.1640 for the last single week of trading, and 3.6723 for the last 200 days.
Telomir Pharmaceuticals Inc (TELO) Capital Structure & Debt Analysis
Telomir Pharmaceuticals Inc (TELO) Efficiency & Liquidity Metrics
Telomir Pharmaceuticals Inc (TELO) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Telomir Pharmaceuticals Inc. (TELO) effectively leverages its workforce, generating an average of -$2504000.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.75% and a Quick Ratio of 0.75%, indicating strong ability to cover short-term liabilities.
Telomir Pharmaceuticals Inc [TELO]: Institutional Ownership
There are presently around $12.53%, or 19.03% of TELO stock, in the hands of institutional investors. The top three institutional holders of TELO stocks are: BLACKROCK INC. with ownership of 87899.0 shares, which is approximately 0.2969%. GEODE CAPITAL MANAGEMENT, LLC, holding 66355.0 shares of the stock with an approximate value of $$0.32 million in TELO stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$0.24 million in TELO stock with ownership which is approximately 0.1694%.
